Amber traffic light, illustration

Featured image by KTS Design/Getty Images

Venture Capital

Why all US crossover funds are averaging just 170 VC deals a quarter

The portfolios of firms that invest in both stocks and startups may have become “bloated” on the venture side.

Crossover fund managers have diminished their venture capital dealmaking as inflated valuations and a lack of exits weigh down portfolios.

Last year’s cumulative US deal value with crossover fund participation was $89.6 billion, according to the latest PitchBook–NVCA Venture Monitor. That’s just over half of the record $172.4 billion in 2021 when hedge funds and other liquid asset managers piled into hot tech startups.

Crossover firms’ pandemic-era enthusiasm for startups has not since held.

These investors have averaged around 170 deals over the last 10 quarters—just one-third of 2021’s quarterly deal flow.

“It’s hard to name even one or two new entrants into the VC asset class of folks raising public funds,” said Zach Ullman, a principal at growth equity firm Lead Edge Capital. He cited Balyasny Asset Management’s first VC fund, targeting $350 million, as a notable exception.

Firms investing in both stocks and startups are simultaneously exposed to public market volatility and ongoing uncertainty about portfolio exit opportunities.

Tariffs have “only served to exacerbate” an already dicey macro environment for crossover strategies, said Silicon Foundry CEO Neal Hansch.

As 2021’s high valuations tapered and down rounds became prevalent, VCs started concentrating their bets on a handful of top growth-stage and mature startups, he said. Now the tariffs’ effects on the markets further drive GPs to write fewer, larger checks.

“Investors are favoring stronger businesses with clear profitability paths, reflecting cautious optimism and a more selective approach to new investments,” said Hansch.

But despite contributing to just 4.9% of all US venture deals last year, deals featuring crossover investors made up 42% of 2024’s total value, according to the report.

Take, for example, D1 Capital’s recent participation in Anthropic‘s $3.5 billion round at a $61.5 billion valuation, or Tiger Global leading Temporal’s $146 million round at a $1.72 billion valuation.

“You can see activity from the crossover funds, where they don’t look and feel like venture rounds,” said Ullman. “They look and feel like more growth-stage, more mature [investments] pre-IPO or could already be public businesses.”

“We haven’t seen crossover funds sniffing, really, even around Series A in a long time,” said Santosh Sankar, co-founder and managing partner of Dynamo Ventures. “We’re seeing much more them staying to the more growth stages.”

For startups seeking capital from crossovers, this narrow focus toward the top end of the market could complicate fundraising, leading to down rounds or an inability to raise, according to PitchBook senior VC analyst Emily Zheng.

“The challenge with crossover investors’ pullback is that their money has been a reliable source of capital for late-stage and venture-growth-stage companies looking to remain private,” she said.

Featured image by KTS Design/Getty Images

Learn about our editorial standards.